| Description | Picrasidine M is a PARP-1 inhibitor. |
| molecular weight | 490.51 |
| Molecular formula | C29H22N4O4 |
| CAS | 99964-79-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Kong L, Wang B, Yang X, Guo H, Zhang K, Zhu Z, Liu J, Hao D. Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production. Cell Physiol Biochem. 2017;43(4):1425-1435. doi: 10.1159/000481874. Epub 2017 Oct 11. PubMed PMID: 29017159. 2. Chen KC, Lee WY, Chen HY, Chen CY. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome. Biomed Res Int. 2014;2014:139492. doi: 10.1155/2014/139492. Epub 2014 Jun 23. PubMed PMID: 25045657; PubMed Central PMCID: PMC4090453. 3. Chen KC, Sun MF, Chen CY. In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine. Evid Based Complement Alternat Med. 2014;2014:917605. doi: 10.1155/2014/917605. Epub 2014 Apr 30. PubMed PMID: 24876881; PubMed Central PMCID: PMC4021748. |